Sankara Eye Hospital-CUHK deal expands paediatric eye care focus as the Indian hospital and the Chinese University of Hong Kong sign a memorandum of understanding to deepen cooperation on childhood vision disorders.
Collaboration targets myopia, ROP and school screening
The agreement outlines joint work on clinical research, education and technology development. Both parties say they will explore ways to slow or prevent myopia progression, study retinopathy of prematurity (ROP) and investigate ocular tumours.
Divya Caculo, a consultant paediatric ophthalmologist at Sankara Eye Hospital in Bengaluru, noted that recent ophthalmic developments are changing care. She cited low‑dose atropine therapy and specialised optical designs as evidence‑based approaches that are already reducing near‑sightedness in children.
Research and technology components
Beyond drug and lens options, the partnership will include genetic testing for inherited retinal disorders. The doctor also mentioned the use of wide‑field retinal imaging combined with anti‑VEGF therapies for treating ROP, a condition that can lead to blindness in premature infants.
Artificial intelligence‑enabled screening tools form another pillar of the plan. “I view AI‑enabled screening tools as a key change, allowing clinicians to map and detect disorders at earlier stages to bridge accessibility gaps in underserved communities,” she said.
Related: Taiwan Sees Rise in Neuroendoscopy Procedures
School‑based vision programs
Namratha Hegde, optometry faculty and lead for institutional research at Sankara, explained that the collaboration will launch vision screening programmes in schools. The goal is early identification and referral of refractive errors, a step that could reduce the need for later corrective surgery.
The memorandum also calls for academic exchange, including faculty visits and joint publications. Researchers from both institutions will have access to shared data sets, which could accelerate the development of new treatment protocols.
External perspective
Professor Alan Cheng, an ophthalmology professor at the University of Sydney who is not involved in the deal, said the initiative reflects a growing trend of cross‑border partnerships in eye care, but the real test will be how quickly findings move from the lab to the clinic. He added that funding and regulatory alignment often pose hurdles for multinational research.
Potential impact on public health
Myopia rates have risen sharply in Asia over the past decade, prompting health authorities to issue guidelines. The World Health Organization notes that myopia could affect half of the world’s population by 2050. If the collaborative efforts succeed, they may provide a model for other regions facing similar challenges.
In addition to clinical work, the memorandum mentions technology development, though details remain vague. The partners have not disclosed specific funding amounts or timelines, leaving some uncertainty about the pace of implementation.
Related: 17 Complete Tips to Improve Your Healthy News
Future steps and community outreach
Both institutions plan to pilot the school screening programme in selected districts of Karnataka and Hong Kong. Data from these pilots will inform larger rollouts, according to the document.
There is also talk of creating a shared digital platform for training optometrists, which could help standardise care across the two countries.
While the agreement signals optimism, the actual benefits for children will depend on how quickly the research translates into affordable, accessible services.
Continued monitoring will be essential.